Skip to main content
NCBI home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1962 Jun;18(3):625–629. doi: 10.1111/j.1476-5381.1962.tb01182.x

Disposition of [35s]-heparin in the rat

Margaret Day, J P Green, J D Robinson
PMCID: PMC1482200  PMID: 19108162

Abstract

[35S]-Heparin is rapidly taken up by tissues after intraperitoneal injection andrapidly degraded. Skin, aorta and lung showed an especially high affinity for[35S]-heparin. In these organs, as well as in adrenal gland, stomach, heart and brain,the isotope was found preponderantly as dialysable metabolite(s) of heparin. Another group of tissues (large intestine, fat, kidney and liver) was characterized by a smaller proportion of dialysable material. Tissues that showed a high affinity for exogenous heparin appeared to catabolize it rapidly. It is also noted that some of the radioactive material present in tissues after the injection of [35S]-heparin could come from the uptake of [35S]-sulphate resulting from the degradation of [35S]-heparin. The incorporation of [35S]-sulphate into the sulphomucopolysaccharides of some tissues is recorded.

Full text

PDF
625

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DANISHEFSKY I., EIBER H. B. Studies on the metabolism of heparin. Arch Biochem Biophys. 1959 Nov;85:53–61. doi: 10.1016/0003-9861(59)90446-1. [DOI] [PubMed] [Google Scholar]
  2. DAVIDSON E. A., RILEY J. G. Chondroitin sulfate B metabolism. Biochim Biophys Acta. 1960 Aug 26;42:566–567. doi: 10.1016/0006-3002(60)90851-9. [DOI] [PubMed] [Google Scholar]
  3. EIBER H. B., DANISHEFSKY I., BORRELLI F. J. Physiological disposition of heparin. Proc Soc Exp Biol Med. 1958 Jul;98(3):672–674. doi: 10.3181/00379727-98-24147. [DOI] [PubMed] [Google Scholar]
  4. GORE I., LARKEY B. J. Functional activity of aortic mucopolysaccharides. J Lab Clin Med. 1960 Dec;56:839–846. [PubMed] [Google Scholar]
  5. GREEN J. P., DAY M. Heparin, 5-hydroxytryptamine, and histamine in neoplastic mast cells. Biochem Pharmacol. 1960 Jun;3:190–205. doi: 10.1016/0006-2952(60)90107-6. [DOI] [PubMed] [Google Scholar]
  6. GREEN J. P. Fractionation of heparin on an anion exchanger. Nature. 1960 May 7;186:472–472. doi: 10.1038/186472a0. [DOI] [PubMed] [Google Scholar]
  7. GREEN J. P., ROBINSON J. D., Jr Cerebroside sulfate (sulfatide A) in some organs of the rat and in a mast cell tumor. J Biol Chem. 1960 Jun;235:1621–1624. [PubMed] [Google Scholar]
  8. HIGGINBOTHAM R. D. On the participation of micellophagosis in the resistance of tissue to injurious agents. Int Arch Allergy Appl Immunol. 1959;15:195–222. doi: 10.1159/000229046. [DOI] [PubMed] [Google Scholar]
  9. LOOMIS T. A. Distribution and excretion of heparin. Proc Soc Exp Biol Med. 1961 Mar;106:490–492. doi: 10.3181/00379727-106-26379. [DOI] [PubMed] [Google Scholar]
  10. ROBINSON D. S., FRENCH J. E. Heparin, the clearing factor lipase, and fat transport. Pharmacol Rev. 1960 Jun;12:241–263. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES